SIA "ABC pharma"Active

40103731414Limited liability companyFounded 2013

Key figures

4 113 440 €+0,7%
Revenue 2025
+55,5%
Average annual growth 2014–2025
02 m4 m6 m’14’15’16’17’18’19’20’21’22’23’24’25

Ratios

2025
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
0500 k1 m1,5 m’14’15’16’17’18’19’20’21’22’23’24’25

Dividends

calculated
2025

Paid out in dividends approximately 500 000 € (55% of equity at the end of the previous year).

Low confidence: the company does not file a cash flow statement, so the amount is an estimate from changes in equity — it may also include other reductions of equity (e.g. a share capital reduction).

History
2025 ~500 000 €
2024 ~499 999 €
2023 ~399 999 €
2022 ~400 001 €
2021 ~379 599 €
2020 ~116 000 €
20190 €
2018 ~106 806 €
20170 €
20160 €
20150 €
Summary of financial statements2014–2025
201420152016201720182019202020212022202320242025
Balance sheet — assets
Total current assets396631 082139 565115 066283 223389 688755 142703 496751 3741 064 7951 013 960984 149
Total non-current assets0017 70014 31810 875893148684757326213 24763 89049 623
Total assets396631 082157 265129 384294 098398 619760 010708 253754 6361 078 0421 077 8501 033 772
Balance sheet — liabilities and equity
Current liabilities020 537019 378215 226103 572208 660100 628129 269202 561174 808202 519
Non-current liabilities95650103 875000000000
Total liabilities956520 537103 87519 378215 226103 572208 660100 628129 269202 561174 808202 519
Share capital————————————
Retained earnings of previous periods————————————
Profit for the year-859916 14442 84556 61775 672216 175372 303435 874417 743650 113527 560428 211
Total equity-559910 54553 390110 00678 872295 047551 350607 625625 367875 481903 042831 253
Income statement
Sales revenue32 097318 572538 044693 607899 3151 629 8472 692 8013 054 0983 065 3373 920 3184 084 6354 113 440
Operating profit-859917 47949 41264 85475 839216 244396 417512 153493 489722 954617 901525 182
Profit before income tax-859917 47949 41264 85475 839216 244395 479510 816492 492721 734616 860524 559
Profit for the reporting year-859916 14442 84556 61775 672216 175372 303435 874417 743650 113527 560428 211
Labour costs————————————
Depreciation of non-current assets————————————
Other indicators
Employees344579111213151417
Calculated dividend—000106 8060116 000379 599400 001399 999499 999500 000

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Connections graph

Click a node to see its other connections.

50%25%25%SIA "ABC pharma"SIA "Baltacon"2Valeine IndraJurševskis Oskars9+Belēvičs Artūrs
CompanyPersonShareholderOther roleAdditional link

Related companies

Summary: SIA "ABC pharma"

Overview

SIA "ABC pharma" (reg. no. 40103731414) is a limited liability company. The company was registered in 2013 and has been in the register for 12 years. Registered address: Rīga, Krūzes iela 38.

Financial results

Revenue in 2025 was 4 113 440 €, up 0,7% on the previous year (4 084 635 €). From 2014 to 2025, revenue grew by an average of 55,5% per year. This is the company's highest revenue among the published years (2014–2025). Net profit for 2025 was 428 211 € (10,4% of revenue). The company was profitable in 11 of the 12 published years. In 2025 the company had 17 employees (14 a year earlier). Revenue per employee was 241 967 €. At the end of 2025, total assets were 1 033 772 € and equity 831 253 € (80,4% of assets).

Management and owners

The board has 2 members. According to the register, the company has 3 owners. The largest stake (50%) is held by SIA "Baltacon".

Data sources and freshness

Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.